Depression, Inflammation, and Longevity: Where Physiology Fits
One-Minute Read
Depression is deeply personal, but it is also biological. Sleep, metabolic health, hormonal transitions, chronic illness, medications, physical activity, stress physiology, and inflammatory signaling can all influence the brain systems involved in mood, motivation, energy, and cognition.
One of the more interesting developments in depression research is the recognition that some people appear to have a more prominent inflammatory phenotype. Recent clinical trials and meta-analyses suggest that this subgroup may respond differently to treatment, although inflammatory markers are not yet used routinely to diagnose depression or select an antidepressant.
This broader view does not compete with psychotherapy or psychiatric care. It adds another layer to the evaluation. Someone struggling with depression may also have fragmented sleep, obstructive sleep apnea, insulin resistance, thyroid disease, a menopausal transition, nutritional deficiencies, chronic pain, cardiovascular risk, or another medical condition influencing how they feel.
At HormoneSynergy®, the purpose of looking at physiology is not to explain away the emotional experience of depression. It is to make sure potentially treatable contributors are not being overlooked.
Depression is often described through emotion: sadness, loss of pleasure, hopelessness, isolation, irritability, or a diminished sense of connection with life. For many people, however, the experience is just as physical. Sleep changes. Energy disappears. Thinking becomes slower. Motivation becomes difficult. Appetite may change. Exercise feels harder. The body can feel heavy in a way that is difficult to separate from the mood itself.
Medicine has become increasingly interested in that overlap.
Research involving the immune system, metabolism, sleep, endocrine physiology, and the brain has made it clear that depression cannot always be understood by separating “mental health” from “physical health.” The two constantly interact.
Dr. Kathryn Retzler approaches this from a straightforward clinical position: depression deserves appropriate mental-health care, and patients also deserve a medical evaluation capable of recognizing physical conditions that may contribute to how they are feeling.
Depression Is Multifactorial
There is no single biologic explanation for depression. Even within major depressive disorder, two people can have very different symptoms, histories, precipitating events, medical conditions, and treatment responses.
Genetics and neurobiology matter. So do relationships, trauma, grief, financial stress, loneliness, illness, work, caregiving, sleep, medications, substance use, hormonal transitions, physical activity, and metabolic health.
These influences often coexist rather than appearing one at a time. A woman moving through perimenopause may be sleeping poorly because of night sweats, noticing changes in mood and cognition, gaining visceral fat, becoming less physically active because she is exhausted, and experiencing significant stress at work or home. Trying to decide which single factor “caused” her symptoms may be less useful than understanding how the pieces interact.
A broader medical evaluation does not make depression less psychological or less human. It recognizes that human beings do not experience emotion independently of the body.
Where Inflammation Fits
Inflammation is a normal part of immune function. It allows us to respond to infection and tissue injury and plays an important role in recovery and repair.
Persistent low-grade inflammatory signaling can also accompany obesity, particularly visceral adiposity, insulin resistance, smoking, inflammatory disease, chronic infection, sleep disruption, and other medical conditions.
Researchers have repeatedly found that inflammatory markers are elevated in a subset of people with major depression. Cytokines such as IL-6 and TNF-alpha and markers such as C-reactive protein have been studied extensively, although results vary across populations and individuals.
The important development is not the idea that everyone with depression has inflammation. It is the emerging recognition that depression may contain biologically distinct subgroups, one of which appears to have more prominent inflammatory physiology.
A 2026 systematic review and meta-analysis of randomized trials specifically examined people with depression and elevated inflammation. Among trials using a CRP threshold of at least 2 mg/L, anti-inflammatory interventions produced modest improvements in depressive symptoms and anhedonia compared with placebo. Response and remission rates were not significantly different, so this remains an evolving area rather than a replacement for standard depression treatment.
Read the 2026 American Journal of Psychiatry meta-analysis.
Inflammatory Markers Add Context, Not a Diagnosis
It is tempting to turn new biology into a new test. Depression is more complicated than that.
CRP and hsCRP are peripheral markers of inflammatory activity. They can rise with infection, obesity, smoking, autoimmune disease, periodontal disease, tissue injury, and many other conditions. They do not tell us that the brain itself is “inflamed,” and they do not diagnose an inflammatory form of depression on their own.
Research into whether inflammatory biomarkers can predict antidepressant response is active. A 2026 meta-analysis of 24 studies found that no individual baseline inflammatory biomarker consistently distinguished antidepressant responders from nonresponders across the full historical evidence base, although several signals remain interesting in newer studies.
Review the updated inflammatory biomarker meta-analysis.
For now, these markers are most useful when they belong to a larger medical question rather than when they are ordered simply to find a biologic explanation for sadness, fatigue, or low motivation.
Sleep Is One of the First Places We Look
Sleep and depression have a complicated relationship because each can worsen the other. Insomnia can precede depression, occur during it, or continue after mood has begun to improve. Some people sleep considerably more during a depressive episode rather than less.
Poor sleep also has measurable effects outside the brain. An updated 2025 meta-analysis of controlled sleep-deprivation studies found that several consecutive nights of partial sleep restriction increased circulating IL-6 and CRP. A single night of poor sleep did not consistently produce the same inflammatory response.
Read the sleep-deprivation and inflammation meta-analysis.
The practical implication is broader than inflammation. Someone who is depressed and sleeping poorly deserves a careful sleep history. Snoring, witnessed apnea, morning headaches, restless legs, daytime sleepiness, menopausal night sweats, alcohol use, medication effects, pain, and circadian disruption can all change sleep quality and daytime brain function.
Obstructive sleep apnea deserves particular attention because treating depression without recognizing clinically significant sleep apnea leaves an important medical problem untouched.
Related HormoneSynergy® resources:
Metabolic Health and Mood Often Travel Together
Metabolic medicine and mental health overlap more than they were once taught to.
A large meta-analysis involving more than 240,000 participants found higher fasting insulin and HOMA-IR in people with acute depression. More recent work has also identified relationships among depressive symptom severity, dysglycemia, dyslipidemia, insulin resistance, sleep disturbance, and anhedonia.
Review the 2025 meta-analysis of depression and metabolic disturbances.
These associations do not mean insulin resistance explains depression. They do tell us that checking metabolic health can be relevant when a patient with depression also has weight gain, visceral adiposity, elevated triglycerides, prediabetes, polycystic ovarian syndrome, sleep apnea, hypertension, or other cardiometabolic risk.
Improving metabolic health can also improve aspects of life that matter regardless of the mechanism: energy, physical capacity, cardiovascular health, sleep, body composition, and long-term disease risk.
Related resources:
- Insulin Resistance and Mental Health
- Fasting Insulin and Metabolic Health
- HOMA-IR and Insulin Resistance
Perimenopause Deserves Particular Attention
Hormonal transitions can influence mood without reducing depression to a “hormone imbalance.” Perimenopause is one of the clearest examples.
A 2024 systematic review and meta-analysis of prospective studies found that women in perimenopause had approximately 40% higher odds of depressive symptoms or a depression diagnosis than premenopausal women. A larger 2026 meta-analysis again found substantial rates of depressive, anxiety, and insomnia symptoms around the menopausal transition.
Review the perimenopause and depression meta-analysis.
This period of life can include fluctuating estradiol, changing menstrual cycles, vasomotor symptoms, fragmented sleep, body-composition changes, sexual symptoms, caregiving stress, relationship changes, and significant professional and family demands. The depressive symptoms are real regardless of which combination of those factors is contributing.
For some women, appropriate menopause treatment can improve sleep, vasomotor symptoms, and overall quality of life. A woman with major depression may still need psychotherapy, antidepressant treatment, psychiatric care, or another mental-health intervention. These approaches are not mutually exclusive.
Thyroid and Other Medical Contributors
Thyroid dysfunction belongs in the differential diagnosis when the clinical history supports it because both hypothyroidism and hyperthyroidism can influence mood, sleep, anxiety, energy, cognition, and physical function.
Other conditions can create similar overlap. Anemia, vitamin B12 deficiency, medication effects, chronic pain, inflammatory disease, neurologic illness, substance use, post-infectious syndromes, and nutritional inadequacy may all influence energy or cognition and sometimes coexist with depression.
The purpose of testing is not to perform every possible laboratory panel. Testing should follow the history, physical findings, medications, risk factors, and symptom pattern.
See Hormones and Mental Health and Thyroid and Mental Health.
Stress Physiology Is More Than a Cortisol Number
Chronic stress has real physiologic effects, but the biology should not be reduced to the idea that every stressed or depressed patient has “high cortisol” or “adrenal fatigue.”
The hypothalamic-pituitary-adrenal axis, autonomic nervous system, sleep, immune system, cardiovascular system, and metabolism all participate in the stress response. The pattern changes with duration, severity, trauma history, sleep, medications, illness, and individual biology.
Clinical care is often more productive when the discussion moves beyond trying to normalize a single stress hormone. Therapy, social connection, movement, sleep restoration, boundaries, treatment of anxiety or depression, meaningful recovery time, and addressing the circumstances producing sustained stress can all be part of care.
Explore Chronic Stress and Longevity.
Movement Has a Place in Depression Care
Physical activity deserves attention because its benefits do not depend on deciding whether depression is psychological, inflammatory, metabolic, or neurologic.
Regular movement and resistance training support insulin sensitivity, cardiovascular health, sleep, muscle preservation, physical confidence, and functional capacity. Exercise also has direct evidence as part of depression management.
For someone in a significant depressive episode, however, “exercise more” can feel dismissive if it is offered as though motivation itself were not part of the illness. The useful approach is to meet the person where they are and build activity gradually as symptoms and capacity allow.
Nutrition Without the “Anti-Inflammatory Diet” Hype
There is no single food plan that treats depression for everyone, but nutritional quality still influences metabolic and cardiovascular health and can support the broader physiology relevant to brain health.
We generally favor a protein-forward Mediterranean-style pattern emphasizing vegetables, fruit, legumes, nuts, seeds, olive oil, fish, minimally processed foods, and adequate protein. For a patient with insulin resistance or significant glucose variability, carbohydrate quality and meal structure may deserve additional attention.
The goal is sustainable nutrition, not a restrictive detox or an endless search for foods supposedly causing brain inflammation.
Where Standard Depression Treatment Fits
Psychotherapy and antidepressant medication remain important treatments for depression. For some patients, psychiatric evaluation, medication adjustment, transcranial magnetic stimulation, ketamine or esketamine therapy, or other specialized treatments may also be appropriate.
Longevity medicine should add to this care rather than position itself against it.
If a patient is sleeping four hours a night, has untreated sleep apnea, significant iron deficiency, symptomatic hypothyroidism, severe menopausal vasomotor symptoms, uncontrolled diabetes, or another treatable medical problem, addressing that condition may make mental-health treatment more effective and improve overall health at the same time.
Conversely, correcting a laboratory abnormality does not eliminate the need to treat major depression appropriately.
The most useful model is collaborative: mental health and physical health addressed together when both are contributing.
The HormoneSynergy® Perspective
At HormoneSynergy®, a patient with persistent low mood, fatigue, loss of motivation, cognitive complaints, or changes in sleep is not automatically placed into an “inflammation protocol.” We begin with the history and the person.
Depending on that history, Dr. Kathryn Retzler may consider sleep and sleep-apnea risk, thyroid function, metabolic health and insulin resistance, cardiovascular risk, nutrition, medication effects, menopausal or other endocrine changes, body composition, exercise, chronic illness, and other medical contributors.
Some patients will have little evidence that these issues are playing a major role. Others will have several treatable problems occurring alongside depression.
This approach complements, rather than replaces, psychotherapy, psychiatric care, medication, relationships, social support, and the personal work involved in recovery.
Depression is not made more legitimate by finding a laboratory abnormality. The value of physiology is that it may reveal another part of the patient's health that can be treated.
This is the framework behind Mental Health and Longevity Medicine and The HormoneSynergy® Longevity Medicine Model.
Physician-Guided Longevity Medicine
HormoneSynergy® evaluates sleep, metabolic health, hormones, cardiovascular risk, nutrition, body composition, cognition, and other medical factors that can influence long-term brain and whole-body health.
Learn About Personalized Longevity MedicineRelated HormoneSynergy® Resources
- Mental Health and Longevity Medicine
- Sleep, Mental Health, and Longevity
- Chronic Stress and Longevity
- Insulin Resistance and Mental Health
- Inflammation and Cognitive Aging
- Inflammation and Longevity Medicine
Frequently Asked Questions
Is depression caused by inflammation?
Not in any simple or universal sense. Research suggests that elevated inflammatory signaling characterizes a subset of people with depression. Depression remains a heterogeneous condition influenced by biological, psychological, social, and environmental factors.
Can inflammation affect mood and motivation?
Yes. Immune signaling can communicate with the brain and influence pathways involved in energy, reward, motivation, and cognition. The degree to which this contributes to depression varies among individuals.
Should I have CRP checked because I am depressed?
Not necessarily. CRP can provide useful medical information in the appropriate setting, particularly for cardiovascular and inflammatory risk assessment, but it is not a diagnostic test for depression or “brain inflammation.” Testing should be based on the broader clinical picture.
Can sleep problems worsen depression?
Yes. Sleep disruption and depression frequently occur together and can influence one another. Persistent sleep restriction can also affect metabolic, cardiovascular, and inflammatory physiology. Sleep apnea and other sleep disorders should be considered when symptoms suggest them.
Can insulin resistance contribute to depression?
Insulin resistance and depression are associated in population and clinical studies, and metabolic disturbances appear more common in some people with depression. That does not establish insulin resistance as the sole cause of depression, but metabolic evaluation may be relevant when other risk factors are present.
Can perimenopause affect depression risk?
Yes. Prospective research shows a higher risk of depressive symptoms and diagnoses during perimenopause compared with the premenopausal years. Sleep disruption, vasomotor symptoms, hormonal fluctuations, life circumstances, and prior mental-health history can all contribute.
Does longevity medicine replace psychotherapy or psychiatric care?
No. Longevity medicine can identify physical and metabolic contributors that deserve treatment, but it does not replace psychotherapy, psychiatric evaluation, antidepressant medication, or other established mental-health treatments when they are needed.
Selected Clinical References
Depressive Symptom Severity and Metabolic Disturbances — Systematic Review and Meta-Analysis, 2025
Risk of Depression Across the Menopausal Transition — Systematic Review and Meta-Analysis, 2024
Editorial Transparency
This article was developed with AI-assisted drafting support and reviewed and edited by the HormoneSynergy® team for clinical accuracy, clarity, and relevance. It reflects the educational perspective of HormoneSynergy® and is not a substitute for individualized medical or mental-health evaluation and treatment.
Important: Depression that is severe, rapidly worsening, or accompanied by thoughts of suicide or self-harm requires prompt professional care. In the United States, call or text 988 for the Suicide & Crisis Lifeline, or seek emergency care when there is immediate danger.
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →